Institute for Applied Cancer Science
In The News
MD Anderson & GlaxoSmithKline to collaborate on new approach to cancer immune therapy; success could earn cancer center $335 million plus royalties.
Read the press release.
Who We Are
The Institute for Applied Cancer Science focuses on accelerating the delivery of new, safe and highly effective therapeutics.
Blending the best attributes of academic science and industrial rigor, it will identify and validate new cancer targets, convert that scientific knowledge into new drugs and advance them into clinical trials. Learn more about us.
Our Approach
-
Experienced Teams
Our programs are supported by integrated teams of experienced scientists with diverse expertise and proven track records of effectively translating targets into therapeutics.
-
Line of Sight to the Clinic
IACS unites drug discovery with clinical research and fundamental cancer biology to maximize the clinical impact of our pipeline.
-
Leveraging Technology
The institute is equipped with state-of-art technology to fully support program efforts in functional genomics, medicinal chemistry, genomics and metabolomics.
